SEC Form 4 · accession 0001179110-16-019789
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Severino
Officer — EVP, R&D and CSO
Period of report
Feb 18, 2016
Accepted (ET)
Feb 22, 2016 · 5:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $54.86 | Feb 18, 2016 | A | 91,990 | A | Feb 18, 2017 | Feb 17, 2026 | Common stock | 91,990 | 91,990 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,664 on 02/18/2017, 30,663 on 02/18/2018, and 30,663 on 02/18/2019.